UTHR Sale Disclosure
Mahon Paul A · SEC Form 4 · Filed Sep 3, 2026
Sale
Calculated transaction value
$77.23K
Mahon Paul A EVP & General Counsel
UTHR
Transaction date
Sep 3, 2026
Public filing date
Sep 3, 2026
Filing lag
Filed same day
UTHR daily price context
Close on/before transaction
$490.24
Sep 3, 2026
Close before public filing
$492.02
Sep 2, 2026
Return since public filing
+1.03%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 160 shares @ $482.66
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001231589-26-000019
Filing cohort
Transactions in this filing
Showing 13 of 13
Trades
13
Issuers
1
Estimated value
$5.21M
Buys / sales
0 / 11
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Sep 3, 2026 | $1.21M |
| United Therapeutics Corp UTHR | Sale | Sep 3, 2026 | $739.95K |
| United Therapeutics Corp UTHR | Sale | Sep 3, 2026 | $448.96K |
| United Therapeutics Corp UTHR | Sale | Sep 3, 2026 | $1.13M |
| United Therapeutics Corp UTHR | Sale | Sep 3, 2026 | $505.05K |
| United Therapeutics Corp UTHR Current | Sale | Sep 3, 2026 | $77.23K |
| United Therapeutics Corp UTHR | Sale | Sep 3, 2026 | $96.77K |
| United Therapeutics Corp UTHR | Sale | Sep 3, 2026 | $462.81K |
| United Therapeutics Corp UTHR | Sale | Sep 3, 2026 | $290.91K |
| United Therapeutics Corp UTHR | Sale | Sep 3, 2026 | $82.36K |
| United Therapeutics Corp UTHR | Sale | Sep 3, 2026 | $4.88K |
| United Therapeutics Corp UTHR | Sale | Sep 3, 2026 | $157.08K |
| United Therapeutics Corp UTHR | Exercise | Sep 3, 2026 | $0 |